This NK immune cell therapy program is designed to support a wide range of goals, from immune management for patients with cancer to general health maintenance and healthy aging through immune system support.

iNK Immune Cell Therapy is a program that utilizes Natural Killer (NK) cells with the goal of supporting and optimizing the body's immune environment.

While it may be incorporated as part of immune condition management for patients with cancer, there has also been growing interest in its use among healthy individuals seeking support for healthy aging and everyday wellness.

This immune-based approach is attracting attention across a wide range of age groups, not only as a strategy for addressing health concerns after illness develops, but also from the perspective of maintaining long-term health through proactive immune management.

Providing Medical Institution

JTK clinic

〒102-0083
2nd Floor, Kojimachi Shimura Building, 4-1-5 Kojimachi, Chiyoda-ku, Tokyo

https://www.jtkclinic.com/

Specialty

(Disease) Chronic Pain, Fibromyalgia
(Disease) Lifestyle-Related Diseases (Hypertension, Diabetes Mellitus, Dyslipidemia)
(Disease) Selected Autoimmune Diseases (e.g., Systemic Lupus Erythematosus)
(Disease) Various Solid Tumors
(Therapy / Procedure) Blood Purification Therapy Using LDL Apheresis (for Hypercholesterolemia and Atherosclerosis)
(Therapy / Procedure) Immune Cell Infusion Therapy (for Various Solid Tumors)
(Therapy / Procedure) Stem Cell Therapy (for Chronic Pain)　
(Treatment / Procedure)iPS Cell-Derived Exosome Therapy (Intravenous Infusion, Intranasal Administration, Intra-Articular Knee Injection, and Inhalation Therapy)　　　　　　　　　　　

Eligibility Criteria/Exclusions for Treatment

Our clinic is barrier-free; however, access from the building entrance to our clinic on the 2nd floor is available only via stairs.

Wheelchair users may access the elevator from the basement level (B1F). However, as our staff must prepare a portable ramp and provide assistance while guiding the wheelchair, advance consultation is required.

We appreciate your understanding and cooperation.

Remarks

Duration
Initial consultation through blood collection: Approximately 90 minutes
Cell culture period: Approximately 3 weeks (21 days)
Intravenous infusion time: Approximately 60 minutes
Treatment Process

Step 1: Initial Visit

Arrival at the clinic
Body temperature measurement
Completion of a medical questionnaire
Medical consultation
Explanation of important treatment information
Completion and signing of the informed consent form
Blood collection for cell processing

Step 2: Cell Culture

Following blood collection, approximately 3 weeks (21 days) are required for immune cell culture and preparation.
An infusion appointment will be scheduled once the cell preparation process is completed.

Step 3: Infusion Visit

Arrival at the clinic on the scheduled infusion date
Body temperature measurement
Medical consultation
Intravenous infusion of cultured immune cells (approximately 60 minutes)

Step 4: Follow-up Planning

Discussion and scheduling of the next infusion session, if applicable
Reservation of the next treatment appointment

Precautions / Contraindications

Medical Conditions Requiring Prior Review and Consultation

A review of current medications is required in advance.
Please provide a current medication list or medication record (such as a medication notebook) before treatment.

Patients with the following medical conditions may require additional evaluation prior to treatment:

Autoimmune diseases: Cell culture yield may be lower than expected in some patients with autoimmune conditions.
Active cancer under treatment: Patients currently undergoing cancer treatment, including radiation therapy, may have reduced immune cell culture yields.

A pre-treatment medical consultation is required to review current and past medical conditions. Please discuss your medical history and any ongoing treatments during the consultation.